Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A2 | O15244 | 1/20 | 0.52 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.52 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14847408 | 0.84 | HSD17B10 (0.46) | SLC22A2SLC22A1SLC22A3TSHRALDH1A1 | |
| SCHEMBL24299172 | 0.84 | ALDH1A1 (0.46) | SLC22A2SLC22A1SLC22A3TSHRALDH1A1 | |
| SCHEMBL27252029 | 0.83 | ALDH1A1 (0.44) | SLC22A2SLC22A1SLC22A3TSHRALDH1A1 | |
| SCHEMBL27251896 | 0.78 | TSHR (0.48) | SLC22A2SLC22A1SLC22A3TSHRALDH1A1 | |
| SCHEMBL25564920 | 0.78 | SLC22A2 (0.56) | SLC22A2SLC22A1SLC22A3TSHRALDH1A1 | |
| SCHEMBL28652450 | 0.78 | SLC22A2 (0.56) | SLC22A2SLC22A1SLC22A3TSHRALDH1A1 | |
| SCHEMBL742186 | 0.78 | SLC22A2 (0.56) | SLC22A2SLC22A1SLC22A3TSHRALDH1A1 | |
| SCHEMBL13632763 | 0.78 | SLC22A2 (0.56) | SLC22A2SLC22A1SLC22A3TSHRALDH1A1 | |
| SCHEMBL27252024 | 0.77 | ALDH1A1 (0.39) | SLC22A2SLC22A1SLC22A3TSHRALDH1A1 | |
| SCHEMBL22423582 | 0.77 | ESR1 (0.54) | TSHRALDH1A1HSD17B10TP53MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260000640-A1 | COMPOSITIONS AND METHODS FOR SKIN CARE | ANTIPODEAN PHARMACEUTICALS INC (NZ) | 2026-01-01 | — | — | US | claimed |
| US-20190008825-A1 | COMPOSITIONS AND METHODS FOR SKIN CARE | ANTIPODEAN PHARMACEUTICALS INC (NZ) | 2019-01-10 | — | — | US | claimed |
| US-20170340603-A1 | COMPOSITIONS AND METHODS FOR SKIN CARE | ANTIPODEAN PHARMACEUTICALS INC (NZ) | 2017-11-30 | — | — | US | claimed |
| US-20170246195-A1 | MITOQUINONE DERIVATIVES USED AS MITOCHONDRIALLY TARGETED ANTIOXIDANTS | ANTIPODEAN PHARMACEUTICALS INC (NZ) | 2017-08-31 | — | — | US | claimed |
| US-20110288055-A1 | MITOQUINONE DERIVATIVES USED AS MITOCHONDRIALLY TARGETED ANTIOXIDANTS | TAYLOR KENNETH MARTIN (NZ) | 2011-11-24 | — | — | US | claimed |
| US-7888335-B2 | Antioxidant: methoxyphenyl alkyl triphenylphosphonium or methoxy dioxocyclohexadiene alkyl triphenylphosphonium derivatives; Parkinson's, Alzheimer's disease, Huntington's Chorea and Friedreich's Ataxia | ANTIPODEAN PHARMACEUTICALS, INC. (US) | 2011-02-15 | — | — | US | claimed |
| US-20090258841-A1 | COMPOSITIONS AND METHODS FOR SKIN CARE | ANTIPODEAN PHARMACEUTICALS, INC. (NZ) | 2009-10-15 | — | — | US | claimed |
| US-20080161267-A1 | Mitoquinone Derivatives Used as Mitochondrially Targeted Antioxidants | ANTIPODEAN PHARMACEUTICALS, INC. (US) | 2008-07-03 | — | — | US | claimed |
| WO-2008062210-A2 | FREE RADICAL TRAPPING | THE UNIVERSITY OF SALFORD (GB) | 2008-05-29 | — | — | WO | claimed |
| US-20070225255-A1 | Use of Mitochondrially Targeted Antioxidant in the Treatment of Liver Diseases and Epithelial Cancers | ORIDIS BIOMED FORSCHUNGS-UND ENTWICKLUNGS GMBH (AT) | 2007-09-27 | — | — | US | claimed |
| EP-1765413-A2 | MITOCHONDRIALLY TARGETED ANTIOXIDANTS IN THE TREATMENT OF LIVER DISEASES AND EPITHELIAL CANCERS | Oridis Biomed Forschungs- und Entwicklungs GmbH (AT) | 2007-03-28 | — | — | EP | claimed |
| JP-2007503387-A | — | — | 2007-02-22 | — | — | JP | claimed |
| US-20060229278-A1 | Mitoquinone derivatives used as mitochondrially targeted antioxidants | ANTIPODEAN PHARMACEUTICALS, INC. (US) | 2006-10-12 | — | — | US | claimed |
| EP-1664069-A1 | MITOQUINONE DERIVATIVES USED AS MITOCHONDRIALLY TARGETED ANTIOXIDANTS | Antipodean Pharmaceuticals, Inc. (US) | 2006-06-07 | — | — | EP | claimed |
| WO-2006005759-A2 | MITOCHONDRIALLY TARGETED ANTIOXIDANTS IN THE TREATMENT OF LIVER DISEASES AND EPITHELIAL CANCERS | ORIDIS BIOMED FORSCHUNGS- UND ENTWICKLUNGS GMBH (AT) | 2006-01-19 | — | — | WO | claimed |
| EP-1047701-B1 | MITOCHONDRIALLY TARGETED ANTIOXIDANTS | ANTIPODEAN BIOTECHNOLOGY LTD (NZ) | 2005-05-25 | — | — | EP | claimed |
| WO-2005019232-A1 | MITOQUINONE DERIVATIVES USED AS MITOCHONDRIALLY TARGETED ANTIOXIDANTS | ANTIPODEAN PHARMACEUTICALS, INC. (US) | 2005-03-03 | — | — | WO | claimed |
| JP-6239737-A | — | — | None | — | — | JP | disclosed |
| WO-1999026582-A2 | MITOCHONDRIALLY TARGETED COMPOUNDS | UNIVERSITY OF OTAGO (NZ) | 1999-06-03 | — | — | WO | disclosed |
| JP-H06239737-A | BRAIN METABOLISM PROMOTING AND MEMORY IMPROVING AGENT | YUNIE:KK | 1994-08-30 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060229278-A1 | Mitoquinone derivatives used as mitochondrially targeted antioxidants | COQ8A, MFN2, SQOR | SLC22A2 717/4885SLC22A1 772/4885SLC22A3 660/4885 |
| US-20080161267-A1 | Mitoquinone Derivatives Used as Mitochondrially Targeted Antioxidants | PRDX5, MT-ND2, TXN2 | SLC22A2 932/4885SLC22A1 994/4885SLC22A3 894/4885 |
| US-20170246195-A1 | MITOQUINONE DERIVATIVES USED AS MITOCHONDRIALLY TARGETED ANTIOXIDANTS | PRDX5, TXN2, MT-ND2 | SLC22A2 1015/4885SLC22A1 1055/4885SLC22A3 945/4885 |
| US-20260000640-A1 | COMPOSITIONS AND METHODS FOR SKIN CARE | TXN2, NDUFA2, NDUFA9 | SLC22A2 255/4885SLC22A1 262/4885SLC22A3 244/4885 |
| US-20070225255-A1 | Use of Mitochondrially Targeted Antioxidant in the Treatment of Liver Diseases and Epithelial Cancers | GLS2, PRDX5, GSR | SLC22A2 1080/4885SLC22A1 923/4885SLC22A3 852/4885 |
| US-20090258841-A1 | COMPOSITIONS AND METHODS FOR SKIN CARE | TFAM, HSPA9, MT-CO3 | SLC22A2 316/4885SLC22A1 287/4885SLC22A3 242/4885 |
| US-20110288055-A1 | MITOQUINONE DERIVATIVES USED AS MITOCHONDRIALLY TARGETED ANTIOXIDANTS | PRDX5, MT-ND2, TXN2 | SLC22A2 932/4885SLC22A1 994/4885SLC22A3 894/4885 |
| US-20190008825-A1 | COMPOSITIONS AND METHODS FOR SKIN CARE | TFAM, HSPA9, MT-CO3 | SLC22A2 316/4885SLC22A1 287/4885SLC22A3 242/4885 |
| US-20170340603-A1 | COMPOSITIONS AND METHODS FOR SKIN CARE | TFAM, HSPA9, MT-CO3 | SLC22A2 316/4885SLC22A1 287/4885SLC22A3 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.